These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31419512)

  • 1. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
    Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleandrin enhances radiotherapy sensitivity in lung cancer by inhibiting the ATM/ATR-mediated DNA damage response.
    Wu Q; Liu X; Wang LM; Yang YH; Pan LF; Zhang JJ; Wang YQ; Yao QH; Ma SL; Zhang SR
    Phytother Res; 2024 Aug; 38(8):4151-4167. PubMed ID: 39136618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity.
    Bao Y; Pan Z; Zhao L; Qiu J; Cheng J; Liu L; Qian D
    J Transl Med; 2024 May; 22(1):519. PubMed ID: 38816831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization effect of quinoline-indole-schiff base derivative 10E on non-small cell lung cancer cells in vitro and in tumor xenografts.
    Liu H; Wang Q; Lan W; Liu D; Huang J; Yao J
    Invest New Drugs; 2024 Aug; 42(4):405-417. PubMed ID: 38880855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer.
    Tang Q; Wu L; Xu M; Yan D; Shao J; Yan S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1368-1379. PubMed ID: 32763454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor.
    Chow Z; Johnson J; Chauhan A; Jeong JC; Castle JT; Izumi T; Weiss H; Townsend CM; Schrader J; Anthony L; Yang ES; Evers BM; Rychahou P
    Cancer Lett; 2024 Aug; 596():216993. PubMed ID: 38801884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer.
    Qiu J; Xia Y; Bao Y; Cheng J; Liu L; Qian D
    J Transl Med; 2024 Mar; 22(1):228. PubMed ID: 38431575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
    Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
    Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies.
    Biray Avci C; Dogan F; Ozates Ay NP; Goker Bagca B; Abbaszadeh Z; Gunduz C
    J Cell Biochem; 2018 Dec; 119(12):9817-9824. PubMed ID: 30145821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
    Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
    Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce
    Pandya VA; Crerar H; Mitchell JS; Patani R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study.
    Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
    Kusoglu A; Goker Bagca B; Ozates Ay NP; Gunduz C; Biray Avci C
    Gene; 2020 Oct; 759():145001. PubMed ID: 32738420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials.
    Luo J; Dai X; Hu H; Chen J; Zhao L; Yang C; Sun J; Zhang L; Wang Q; Xu S; Xu Y; Liu N; Ying G; Wang P
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):721-737. PubMed ID: 31786739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatment.
    Gala K; Jain M; Shah P; Pandey A; Garg M; Khattar E
    Life Sci; 2024 Feb; 339():122416. PubMed ID: 38216120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of DNA‑PK activity sensitizes A549 cells to X‑ray irradiation by inducing the ATM‑dependent DNA damage response.
    Yang L; Yang X; Tang Y; Zhang D; Zhu L; Wang S; Wang B; Ma T
    Mol Med Rep; 2018 Jun; 17(6):7545-7552. PubMed ID: 29620203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
    Kim TW; Hong DW; Park JW; Hong SH
    Br J Cancer; 2020 Dec; 123(12):1737-1748. PubMed ID: 32958825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC).
    Dunne VL; Ghita-Pettigrew M; Redmond KM; Small DM; Weldon S; Taggart CC; Prise KM; Hanna GG; Butterworth KT
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
    Liu B; Chen W; Li H; Li F; Jin X; Li Q
    Radiat Environ Biophys; 2020 Nov; 59(4):723-732. PubMed ID: 32857208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
    Pourbagheri-Sigaroodi A; Bashash D; Safaroghli-Azar A; Farshi-Paraasghari M; Momeny M; Mansoor FN; Ghaffari SH
    Eur J Pharmacol; 2019 Mar; 846():49-62. PubMed ID: 30658112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.